Bessemer Group Inc Harrow Health, Inc. Transaction History
Bessemer Group Inc
- $61.3 Billion
- Q4 2024
A detailed history of Bessemer Group Inc transactions in Harrow Health, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 90 shares of HROW stock, worth $2,871. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90
Previous 90
-0.0%
Holding current value
$2,871
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
187Shares Held
21.5MCall Options Held
650KPut Options Held
1.19M-
Opaleye Management Inc. Boston, MA3.99MShares$127 Million26.33% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$68.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$59.7 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.69MShares$54.1 Million6.85% of portfolio
-
Braidwell LP Stamford, CT907KShares$28.9 Million1.7% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $864M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...